Xiaoniu He

2PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 24, 2026
Mitochondrial NADP(H)-dependent de novo dTMP biosynthesis counteracts the cytotoxicity of PARP inhibitors.

|Feb 14, 2025
HDAC2-Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple-Negative Breast Cancer.

Xiaoniu He, Yuanpei Li, Jian Li

Pageof 1

Frequent Collaborators

1 joint publications

Tong Shu

1 joint publications

Yuanpei Li

1 joint publications

Lei Zhang

1 joint publications

Huiwen Zhang